Corporate
News release
TopTOKYO, JAPAN - February 4, 2021 - Terumo Corporation (TSE: 4543) today announced that it will establish the 'DX Promotion Department' on April 1, 2021.
The DX Promotion Department will design a digital transformation (DX) strategy for the entire Terumo Group. It aims to drive "DX for business creation" that will heighten value proposition to customers, and expedite "DX for operation" to increase efficiency and level up the company's value chain.
Over the years, Terumo has worked on various projects that utilize digital technology, such as pharmaceutical infusion pumps linked with hospital IT systems and platforms to support heart disease treatments. The company has also advanced digitalization in its operations such as the global integration of ERP systems.
By establishing the new organization, Terumo will strive to achieve further growth, through transformation in both business creation and operation from a Group-wide perspective.
About Terumo
Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.